Why Pregnancy Weight Gain Guidelines Need to Differ for Multiple Versus Single Pregnancies

Manisha Gandhi1

  • 1Baylor College of Medicine, 6651 Main St, Suite 1096, Houston, TX, 77030, USA. manishag@bcm.edu.

Insights

Gestational weight gain impacts maternal and infant health in both singleton and twin pregnancies. Current guidelines appear beneficial for normal BMI, but more research is needed for diverse populations.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Reproductive Health

Background:

  • Gestational weight gain significantly influences maternal and infant health outcomes.
  • Research on singleton gestations is more extensive than on twin gestations.
  • Existing data are primarily observational and retrospective.

Purpose of the Study:

  • To compare physiological and metabolic changes in singleton versus twin gestations.
  • To review pregnancy outcomes in relation to current gestational weight gain guidelines.

Main Methods:

  • Review of existing literature on singleton and twin gestations.
  • Analysis of studies examining the association between gestational weight gain and pregnancy outcomes.
  • Comparison of findings across different gestation types and adherence to guidelines.

Main Results:

  • In singleton gestations, inadequate weight gain is linked to small for gestational age infants and increased neonatal morbidities.
  • In twin gestations, adequate or excessive weight gain is associated with longer gestations, reduced preterm birth, and higher birth weights.
  • Current Institute of Medicine weight gain guidelines are supported for normal BMI in both singleton and twin gestations.

Conclusions:

  • Gestational weight gain is a critical factor for maternal and infant well-being in both singleton and twin pregnancies.
  • Evidence supports current guidelines for women with normal BMI.
  • Further research is warranted for underweight/overweight women and long-term outcomes.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
161
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
128
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
162